Literature DB >> 26910450

HUMAN T-LYMPHOTROPIC VIRUS 1 (HTLV-1) AND HUMAN T-LYMPHOTROPIC VIRUS 2 (HTLV-2): GEOGRAPHICAL RESEARCH TRENDS AND COLLABORATION NETWORKS (1989-2012).

Gregorio González-Alcaide1, José Manuel Ramos2, Charles Huamaní3, Carmen de Mendoza4, Vicent Soriano4.   

Abstract

Publications are often used as a measure of research work success. Human T-lymphotropic virus (HTLV) type 1 and 2 are human retroviruses, which were discovered in the early 1980s, and it is estimated that 15-20 million people are infected worldwide. This article describes a bibliometric review and a coauthorship network analysis of literature on HTLV indexed in PubMed in a 24-year period. A total of 7,564 documents were retrieved, showing a decrease in the number of documents from 1996 to 2007. HTLV manuscripts were published in 1,074 journals. Japan and USA were the countries with the highest contribution in this field (61%) followed by France (8%). Production ranking changed when the number of publications was normalized by population (Dominican Republic and Japan), by gross domestic product (Guinea-Bissau and Gambia), and by gross national income per capita (Brazil and Japan). The present study has shed light on some of the defining features of scientific collaboration performed by HTLV research community, such as the existence of core researchers responsible for articulating the development of research in the area, facilitating wider collaborative relationships and the integration of new authors in the research groups.

Entities:  

Mesh:

Year:  2016        PMID: 26910450      PMCID: PMC4793952          DOI: 10.1590/S1678-9946201658011

Source DB:  PubMed          Journal:  Rev Inst Med Trop Sao Paulo        ISSN: 0036-4665            Impact factor:   1.846


  41 in total

1.  The actual citation impact of European oncological research.

Authors:  Carmen López-Illescas; Félix de Moya-Anegón; Henk F Moed
Journal:  Eur J Cancer       Date:  2007-11-26       Impact factor: 9.162

2.  Analysis of the leprosy literature indexed in Medline (1950-2007).

Authors:  Dirk Schoonbaert; Veerle Demedts
Journal:  Lepr Rev       Date:  2008-12       Impact factor: 0.537

3.  Falls in patients with HTLV-I-associated myelopathy/tropical spastic paraparesis (HAM/TSP).

Authors:  L D Facchinetti; A Q Araújo; G L Chequer; M F de Azevedo; R V C de Oliveira; M A Lima
Journal:  Spinal Cord       Date:  2012-11-20       Impact factor: 2.772

Review 4.  Seroepidemiology of HTLV-I/II in Argentina: an overview.

Authors:  Rene Gastaldello; William W Hall; Sandra Gallego
Journal:  J Acquir Immune Defic Syndr       Date:  2004-03-01       Impact factor: 3.731

Review 5.  An HTLV-I vaccine: why, how, for whom?

Authors:  G de Thé; R Bomford
Journal:  AIDS Res Hum Retroviruses       Date:  1993-05       Impact factor: 2.205

Review 6.  Human T-lymphotropic virus type II and neurological disease.

Authors:  Abelardo Araujo; William W Hall
Journal:  Ann Neurol       Date:  2004-07       Impact factor: 10.422

7.  A bibliometric analysis of tuberculosis research indexed in PubMed, 1997-2006.

Authors:  J M Ramos; S Padilla; M Masiá; F Gutiérrez
Journal:  Int J Tuberc Lung Dis       Date:  2008-12       Impact factor: 2.373

Review 8.  HTLV-3/STLV-3 and HTLV-4 viruses: discovery, epidemiology, serology and molecular aspects.

Authors:  Renaud Mahieux; Antoine Gessain
Journal:  Viruses       Date:  2011-07-08       Impact factor: 5.048

9.  Research on motor neuron diseases konzo and neurolathyrism: trends from 1990 to 2010.

Authors:  Delphin Diasolua Ngudi; Yu-Haey Kuo; Marc Van Montagu; Fernand Lambein
Journal:  PLoS Negl Trop Dis       Date:  2012-07-31

10.  Variant human T-cell lymphotropic virus type 1c and adult T-cell leukemia, Australia.

Authors:  Lloyd Einsiedel; Olivier Cassar; Peter Bardy; Daniel Kearney; Antoine Gessain
Journal:  Emerg Infect Dis       Date:  2013-10       Impact factor: 6.883

View more
  7 in total

1.  Novel Genetic Constructs for Production of Recombinant HTLV-1/2 Antigens and Evaluation of Their Reactivity to Plasma Samples from HTLV-1-Infected Patients.

Authors:  Ueriton Dias de Oliveira; Fred Luciano Neves Santos; Bernardo Galvão-Castro; Marco Aurelio Krieger; Nilson Ivo Tonin Zanchin
Journal:  J Clin Microbiol       Date:  2021-03-19       Impact factor: 5.948

2.  Spread of Human T-Lymphotropic Virus 1 and 2 Among Relatives of People Who Use Illicit Drugs in Northern Brazil.

Authors:  Aldemir Branco Oliveira-Filho; Paula Cristina Rodrigues Frade; Ricardo Roberto de Souza Fonseca; Leila Sawada; Luísa Caricio Martins; Luiz Fernando Almeida Machado; Antonio Carlos Rosário Vallinoto; Ricardo Ishak; José Alexandre Rodrigues de Lemos; Benedikt Fischer; Emil Kupek
Journal:  Front Microbiol       Date:  2022-06-03       Impact factor: 6.064

3.  Clinical and laboratory features of HTLV-I asymptomatic carriers and patients with HTLV-I-associated myelopathy/tropical spastic paraparesis from the Brazilian Amazon.

Authors:  Massanobu Takatani; Myuki Esashika Crispim; Nelson Fraiji; Mariane Martins Araujo Stefani; Dagmar Kiesslich
Journal:  Rev Inst Med Trop Sao Paulo       Date:  2017-04-03       Impact factor: 1.846

Review 4.  A snapshot of pneumonia research activity and collaboration patterns (2001-2015): a global bibliometric analysis.

Authors:  José M Ramos-Rincón; Héctor Pinargote-Celorio; Isabel Belinchón-Romero; Gregorio González-Alcaide
Journal:  BMC Med Res Methodol       Date:  2019-09-05       Impact factor: 4.615

5.  Human T-lymphotropic virus 1 and 2 among people who used illicit drugs in the state of Pará, northern Brazil.

Authors:  Aldemir B Oliveira-Filho; Ana Paula S Araújo; Andreia Polliana C Souza; Camila M Gomes; Gláucia C Silva-Oliveira; Luísa C Martins; Benedikt Fischer; Luiz Fernando A Machado; Antonio Carlos R Vallinoto; Ricardo Ishak; José Alexandre R Lemos; Emil Kupek
Journal:  Sci Rep       Date:  2019-10-14       Impact factor: 4.379

6.  From cut-points to key players in co-authorship networks: a case study in ventilator-associated pneumonia research.

Authors:  Gregorio González-Alcaide; Héctor Pinargote; José M Ramos
Journal:  Scientometrics       Date:  2020-02-28       Impact factor: 3.238

7.  Interaction of perforin and granzyme B and HTLV-1 viral factors is associated with Adult T cell Leukemia development.

Authors:  Mohammad Mehdi Akbarin; Sadegh Farhadi; Abolghasem Allahyari; Mohammad Mehdi Koshayar; Abbas Shirdel; Hossein Rahimi; Seyed Abdolrahim Rezaee; Maryam Mahdifar; Zahra Mozaheb; Asadollah Mohamadi; Alireza Bari; SeyedehTahereh Mohaddes; Houshang Rafatpanah
Journal:  Iran J Basic Med Sci       Date:  2020-08       Impact factor: 2.699

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.